Literature DB >> 29119230

Re-evaluation of protein kinase CK2 pleiotropy: new insights provided by a phosphoproteomics analysis of CK2 knockout cells.

Cinzia Franchin1,2, Christian Borgo1, Luca Cesaro2, Silvia Zaramella1,2, Jordi Vilardell1, Mauro Salvi3, Giorgio Arrigoni4,5, Lorenzo A Pinna6,7.   

Abstract

CK2 denotes a ubiquitous and pleiotropic protein kinase whose holoenzyme is composed of two catalytic (α and/or α') and two regulatory β subunits. The CK2 consensus sequence, S/T-x-x-D/E/pS/pT is present in numerous phosphosites, but it is not clear how many of these are really generated by CK2. To gain information about this issue, advantage has been taken of C2C12 cells entirely deprived of both CK2 catalytic subunits by the CRISPR/Cas9 methodology. A comparative SILAC phosphoproteomics analysis reveals that, although about 30% of the quantified phosphosites do conform to the CK2 consensus, only one-third of these are substantially reduced in the CK2α/α'(-/-) cells, consistent with their generation by CK2. A parallel study with C2C12 cells deprived of the regulatory β subunit discloses a role of this subunit in determining CK2 targeting. We also find that phosphosites notoriously generated by CK2 are not fully abrogated in CK2α/α'(-/-) cells, while some phosphosites unrelated to CK2 are significantly altered. Collectively taken our data allow to conclude that the phosphoproteome generated by CK2 is not as ample and rigidly pre-determined as it was believed before. They also show that the lack of CK2 promotes phosphoproteomics perturbations attributable to kinases other than CK2.

Entities:  

Keywords:  Cell signalling; Kinase inhibitors; Protein phosphorylation; Quantitative proteomics; Sequence logo

Mesh:

Substances:

Year:  2017        PMID: 29119230     DOI: 10.1007/s00018-017-2705-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  54 in total

1.  The raison d'être of constitutively active protein kinases: the lesson of CK2.

Authors:  Lorenzo A Pinna
Journal:  Acc Chem Res       Date:  2003-06       Impact factor: 22.384

2.  A bead-based approach for large-scale identification of in vitro kinase substrates.

Authors:  Manyu Zhang; Guanghui Han; Chunli Wang; Kai Cheng; Ruibin Li; Hongwei Liu; Xiaoluan Wei; Mingliang Ye; Hanfa Zou
Journal:  Proteomics       Date:  2011-11-23       Impact factor: 3.984

3.  Phosphorylation of RanGAP1 stabilizes its interaction with Ran and RanBP1.

Authors:  Eri Takeda; Miki Hieda; Jun Katahira; Yoshihiro Yoneda
Journal:  Cell Struct Funct       Date:  2005       Impact factor: 2.212

Review 4.  Protein kinase CK2: a challenge to canons.

Authors:  Lorenzo A Pinna
Journal:  J Cell Sci       Date:  2002-10-15       Impact factor: 5.285

Review 5.  From phosphoproteins to phosphoproteomes: a historical account.

Authors:  Andrea Venerando; Luca Cesaro; Lorenzo A Pinna
Journal:  FEBS J       Date:  2017-02-11       Impact factor: 5.542

6.  Investigation on PLK2 and PLK3 substrate recognition.

Authors:  M Salvi; E Trashi; G Cozza; C Franchin; G Arrigoni; L A Pinna
Journal:  Biochim Biophys Acta       Date:  2012-07-21

7.  Identification of the ribosomal proteins phosphorylated by the ribosome-associated casein kinase type II from cryptobiotic gastrulae of the brine shrimp Artemia sp.

Authors:  C Thoen; E De Herdt; H Slegers
Journal:  Biochem Biophys Res Commun       Date:  1986-03-13       Impact factor: 3.575

Review 8.  The phosphorylation of α-synuclein: development and implication for the mechanism and therapy of the Parkinson's disease.

Authors:  Yan Xu; Yulin Deng; Hong Qing
Journal:  J Neurochem       Date:  2015-08-03       Impact factor: 5.372

9.  Modulation of human checkpoint kinase Chk1 by the regulatory beta-subunit of protein kinase CK2.

Authors:  Barbara Guerra; Olaf-Georg Issinger; Jean Y J Wang
Journal:  Oncogene       Date:  2003-08-07       Impact factor: 9.867

10.  Generation and quantitative proteomics analysis of CK2α/α'(-/-) cells.

Authors:  Christian Borgo; Cinzia Franchin; Stefano Scalco; Valentina Bosello-Travain; Arianna Donella-Deana; Giorgio Arrigoni; Mauro Salvi; Lorenzo A Pinna
Journal:  Sci Rep       Date:  2017-02-17       Impact factor: 4.379

View more
  14 in total

1.  Okur-Chung neurodevelopmental syndrome-linked CK2α variants have reduced kinase activity.

Authors:  I Dominguez; J M Cruz-Gamero; V Corasolla; N Dacher; S Rangasamy; A Urbani; V Narayanan; H Rebholz
Journal:  Hum Genet       Date:  2021-05-04       Impact factor: 4.132

2.  CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in huntington's disease.

Authors:  Dahyun Yu; Nicole Zarate; Angel White; De'jah Coates; Wei Tsai; Carmen Nanclares; Francesco Cuccu; Johnny S Yue; Taylor G Brown; Rachel H Mansky; Kevin Jiang; Hyuck Kim; Tessa Nichols-Meade; Sarah N Larson; Katherine Gundry; Ying Zhang; Cristina Tomas-Zapico; Jose J Lucas; Michael Benneyworth; Gülin Öz; Marija Cvetanovic; Alfonso Araque; Rocio Gomez-Pastor
Journal:  Acta Neuropathol Commun       Date:  2022-06-03       Impact factor: 7.578

3.  IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia.

Authors:  Chunhua Song; Zheng Ge; Yali Ding; Bi-Hua Tan; Dhimant Desai; Krishne Gowda; Shantu Amin; Raghavendra Gowda; Gavin P Robertson; Feng Yue; Suming Huang; Vladimir Spiegelman; Jonathon L Payne; Mark E Reeves; Zafer Gurel; Soumya Iyer; Pavan Kumar Dhanyamraju; Meixian Xiang; Yuka Imamura Kawasawa; Nathalia M Cury; José Andrés Yunes; Mary McGrath; Joe Schramm; Ruijun Su; Yiping Yang; Zhijun Zhao; Xiaoguang Lyu; Markus Muschen; Kimberly J Payne; Chandrika Gowda; Sinisa Dovat
Journal:  Blood       Date:  2020-09-24       Impact factor: 22.113

Review 4.  CK2 inhibition protects white matter from ischemic injury.

Authors:  Selva Baltan; Chinthasagar Bastian; John Quinn; Danielle Aquila; Andrew McCray; Sylvain Brunet
Journal:  Neurosci Lett       Date:  2018-08-17       Impact factor: 3.197

5.  A π-Halogen Bond of Dibenzofuranones with the Gatekeeper Phe113 in Human Protein Kinase CK2 Leads to Potent Tight Binding Inhibitors.

Authors:  Alexander Schnitzler; Andreas Gratz; Andre Bollacke; Michael Weyrich; Uwe Kuckländer; Bernhard Wünsch; Claudia Götz; Karsten Niefind; Joachim Jose
Journal:  Pharmaceuticals (Basel)       Date:  2018-02-17

6.  Effects of CK2β subunit down-regulation on Akt signalling in HK-2 renal cells.

Authors:  Estefania Alcaraz; Jordi Vilardell; Christian Borgo; Eduard Sarró; Maria Plana; Oriano Marin; Lorenzo A Pinna; José R Bayascas; Anna Meseguer; Mauro Salvi; Emilio Itarte; Maria Ruzzene
Journal:  PLoS One       Date:  2020-01-07       Impact factor: 3.240

7.  Protein Kinase CK2 Subunits Differentially Perturb the Adhesion and Migration of GN11 Cells: A Model of Immature Migrating Neurons.

Authors:  Antonella Lettieri; Christian Borgo; Luca Zanieri; Claudio D'Amore; Roberto Oleari; Alyssa Paganoni; Lorenzo A Pinna; Anna Cariboni; Mauro Salvi
Journal:  Int J Mol Sci       Date:  2019-11-26       Impact factor: 5.923

8.  Contribution of the CK2 Catalytic Isoforms α and α' to the Glycolytic Phenotype of Tumor Cells.

Authors:  Francesca Zonta; Christian Borgo; Camila Paz Quezada Meza; Ionica Masgras; Andrea Rasola; Mauro Salvi; Lorenzo A Pinna; Maria Ruzzene
Journal:  Cells       Date:  2021-01-18       Impact factor: 6.600

9.  Phenotypic proteomic profiling identifies a landscape of targets for circadian clock-modulating compounds.

Authors:  Sandipan Ray; Radoslaw Lach; Kate J Heesom; Utham K Valekunja; Vesela Encheva; Ambrosius P Snijders; Akhilesh B Reddy
Journal:  Life Sci Alliance       Date:  2019-12-02

10.  PGRMC1 effects on metabolism, genomic mutation and CpG methylation imply crucial roles in animal biology and disease.

Authors:  Bashar M Thejer; Partho P Adhikary; Sarah L Teakel; Johnny Fang; Paul A Weston; Saliya Gurusinghe; Ayad G Anwer; Martin Gosnell; Jalal A Jazayeri; Marina Ludescher; Lesley-Ann Gray; Michael Pawlak; Robyn H Wallace; Sameer D Pant; Marie Wong; Tamas Fischer; Elizabeth J New; Tanja N Fehm; Hans Neubauer; Ewa M Goldys; Jane C Quinn; Leslie A Weston; Michael A Cahill
Journal:  BMC Mol Cell Biol       Date:  2020-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.